• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

Background In patients with acute coronary syndrome and multivessel coronary disease,
complete revascularisation by percutaneous coronary intervention (PCI) is associated with …

always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …

Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …

Aims In patients with acute myocardial infarction (MI) and multivessel coronary artery
disease, percutaneous coronary intervention (PCI) of non-infarct-related artery reduces …

comprehensive review of the published evidence for management of a given condition
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …

Background In patients who have acute myocardial infarction with cardiogenic shock, early
revascularization of the culprit artery by means of percutaneous coronary intervention (PCI) …

Background: A large proportion of patients presenting with non–ST-segment elevation
myocardial infarction (NSTEMI) present with multivessel disease (MVD). There is uncertainty …